Liporaxel
ApprovedOral paclitaxel approved and sold in China for gastric cancer, with an exclusive agreement for Vietnam.
FROM PUBLIC EVENTS · 2026-11-15
Global approvals · expansion Has signed an agreement extending its oral cancer drug from China to Vietnam.
Roles often seen at this stageBD & licensing · Regulatory affairs · Manufacturing & MSAT
A pharmaceutical maker commercialising Liporaxel, an oral paclitaxel cancer drug, with overseas partners in China, Vietnam and elsewhere.
Oral paclitaxel approved and sold in China for gastric cancer, with an exclusive agreement for Vietnam.
Signed an exclusive licence, supply and distribution agreement for Liporaxel in Vietnam.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.